Middle East and Africa Newborn Screening Market - Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET

1.4 LIMITATIONS

1.5 CURRENCY AND PRICING

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 SECONDARY SOURCES

2.7 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING PREVALENCE OF NEWBORN SCREENING

3.1.2 GROWTH IN NEONATAL DISEASES

3.1.3 INCREASED GOVERNMENT INITIATIVES

3.1.4 TECHNOLOGICAL ADVANCEMENTS IN SCREENING

3.2 RESTRAINTS

3.2.1 STRINGENT REGULATORY POLICIES

3.2.2 HIGH COST OF AUTOMATED DEVICES

3.3 OPPORTUNITIES

3.3.1 NEXT-GENERATION SEQUENCING TECHNOLOGY FOR NEWBORN SCREENING

3.3.2 EMERGING MARKET

3.4 CHALLENGES

3.4.1 SOCIO ECONOMIC BARRIERS

3.4.2 LACK OF SKILLED PROFESSIONALS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE

6.1 OVERVIEW

6.2 DRIED BLOOD SPOT TEST

6.3 HEARING SCREEN TEST

6.4 CRITICAL CONGENITAL HEART DISEASES (CCHD) TEST

7 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 INSTRUMENTS

7.2.1 NEWBORN DISORDER SCREENING INSTRUMENTS

7.2.2 NEWBORN HEARING SCREENING INSTRUMENTS

7.2.3 PULSE OXIMETER

7.3 REAGENTS AND ASSAY KITS

8 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 TANDEM MASS SPECTROMETRY

8.3 HEARING SCREEN TECHNOLOGY

8.4 PULSE OXIMETRY SCREENING TECHNOLOGY

8.5 IMMUNOASSAYS AND ENZYMATIC ASSAYS

8.6 ELECTROPHORESIS

8.7 DNA-BASED ASSAYS

9 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY DISEASE TYPE

9.1 OVERVIEW

9.2 CRITICAL CONGENITAL HEART DISEASES

9.3 NEWBORN HEARING LOSS

9.4 SICKLE CELL DISEASE

9.5 PHENYLKETONURIA (PKU)

9.6 CYSTIC FIBROSIS (CF)

9.7 MAPLE SYRUP URINE DISEASE

9.8 OTHERS

10 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITAL

10.3 PEDIATRIC CLINICS

10.4 CLINICS

11 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY GEOGRAPHY

11.1 MIDDILE EAST AND AFRICA

11.1.1 SOUTH AFRICA

11.1.2 REST OF MIDDLE EAST & AFRICA

11.1.3 EGYPT

11.1.4 SAUDI ARAIA

11.1.5 UNITED ARAB EMIRATES

11.1.6 ISRAEL

12 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

13 COMPANY PROFILES

13.1 PERKINELMER INC.

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 PRODUCT PORTFOLIO

13.1.4 RECENT DEVELOPMENTS

13.2 NATUS MEDICAL INCORPORATED

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 PRODUCT PORTFOLIO

13.2.4 RECENT DEVELOPMENTS

13.3 TRIVITRON HEALTHCARE

13.3.1 COMPANY SNAPSHOT

13.3.2 PRODUCT PORTFOLIO

13.3.3 RECENT DEVELOPMENTS

13.4 BAEBIES, INC.

13.4.1 COMPANY SNAPSHOT

13.4.2 PRODUCT PORTFOLIO

13.4.3 RECENT DEVELOPMENTS

13.5 BIO-RAD LABORATORIES, INC.

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 PRODUCT PORTFOLIO

13.5.4 RECENT DEVELOPMENT

13.6 DANAHER

13.6.1 COMPANY SNAPSHOT

13.6.2 REVENUE ANALYSIS

13.6.3 PRODUCT PORTFOLIO

13.6.4 RECENT DEVELOPMENT

13.7 HILL-ROM SERVICES INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENT

13.8 INTELLIGENT HEARING SYSTEMS

13.8.1 COMPANY SNAPSHOT

13.8.2 PRODUCT PORTFOLIO

13.8.3 RECENT DEVELOPMENT

13.9 INTERACOUSTICS A/S

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENTS

13.10 MASIMO

13.10.1 COMPANY SNAPSHOT

13.10.2 REVENUE ANALYSIS

13.10.3 PRODUCT PORTFOLIO

13.10.4 RECENT DEVELOPMENT

13.11 MEDTRONIC

13.11.1 COMPANY SNAPSHOT

13.11.2 REVENUE ANALYSIS

13.11.3 PRODUCT PORTFOLIO

13.11.4 RECENT DEVELOPMENT

13.12 OTODYNAMICS LTD

13.12.1 COMPANY SNAPSHOT

13.12.2 PRODUCT PORTFOLIO

13.12.3 RECENT DEVELOPMENTS

13.13 VIVASONIC INC.

13.13.1 COMPANY SNAPSHOT

13.13.2 PRODUCT PORTFOLIO

13.13.3 RECENT DEVELOPMENTS

13.14 ZENTECH S.A.

13.14.1 COMPANY SNAPSHOT

13.14.2 PRODUCT PORTFOLIO

13.14.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

UU

TABLE 1 NEWBORN SCREENING PROGRAM (2015 & 2016) IN THE U.S.

TABLE 2 NEONATAL MORTALITY RATE (DEATHS PER 1,000 LIVE BIRTHS), IN BETWEEN 2015 -2018

TABLE 3 PREVALENCE OF DISORDERS AMONG FILIPINO NEWBORNS (1996-2016)

TABLE 4 NUMBER OF BIRTHS IN NORTHERN HEMISPHERE (2018)

TABLE 5 PREVALENCE OF DISORDERS AMONG NORTHERN HEMISPHERE (2018)

TABLE 6 COSTS OF NEXT GENENARATION SEQUENCING DEVICES (USD MILLION)

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION)

TABLE 8 COMPARISON OF THE ECONOMIC PROSPERITY AND ANNUAL PERCENTAGE OF NEWBORN BABIES SCREENED IN SELECTED DEVELOPING NATIONS

TABLE 9 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA DRIED BLOOD SPOT TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA HEARING SCREEN TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA CRITICAL CONGENITAL HEART DISEASES TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA PRODUCT IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA REAGENTS AND ASSAY KITS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA TANDEM MASS SPECTROMETRY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA HEARING SCREEN TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA PULSE OXIMETRY SCREENING TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA IMMUNOASSAYS AND ENZYMATIC ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA ELECTROPHORESIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA DNA-BASED ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA CRITICAL CONGENITAL HEART DISEASES IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA NEWBORN HEARING LOSS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA SICKLE CELL DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA PHENYLKETONURIA IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA CYSTIC FIBROSIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA MAPLE SYRUP URINE DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA OTHERS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA HOSPITAL IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA PEDIATRIC CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 43 SOUTH AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 44 SOUTH AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 45 SOUTH AFRICA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 46 SOUTH AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 47 SOUTH AFRICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 48 SOUTH AFRICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 49 REST OF MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)